All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
This article was originally published in The Rose Sheet
Executive Summary
Senate HELP committee leaders release a draft bill for discussion that builds on the Sunscreen Innovation Act and its proposed deadlines for FDA review of sunscreen TEA applications, adding provisions that would require FDA to set “reasonable” review deadlines for all OTC ingredient TEAs.